Immunoassay analysis of standardized brain regions from postmortem human tissue similarly showed no difference in CRFBP expression between AD and control brains, however, CRF was significantly decreased in the frontal, parietal, and temporal brain regions of AD patients compared to control (Behan et al., 1995b). This evidence concerns the gene CRHBP and Alzheimer disease.